Valsartan Dosage Recommendations for Hypertension and Heart Failure
For adults with hypertension, the recommended dosage range for valsartan is 80-320 mg once daily, while for heart failure patients, the target dose is 160 mg twice daily (320 mg total daily dose). 1, 2
Dosage for Hypertension
- The recommended starting dose for hypertension is 80 mg or 160 mg once daily in patients who are not volume-depleted 1
- Dosage may be increased to a maximum of 320 mg daily, administered once a day 1
- The antihypertensive effect is substantially present within 2 weeks, with maximal reduction generally attained after 4 weeks 1
- If additional blood pressure reduction is required, the dose may be increased or a diuretic may be added 1
- Higher doses provide greater benefits, with the 160 mg dose achieving sustained AT1-receptor blockade over 24 hours 3
Dosage for Heart Failure
- The recommended starting dose for heart failure is 40 mg twice daily 1
- Uptitrate to 80 mg and then 160 mg twice daily, or to the highest dose tolerated by the patient 1, 2
- The target dose is 160 mg twice daily (320 mg total daily dose), with at least 50% of target dose (160 mg daily) recommended as the minimum effective dose 2
- Consider reducing the dose of concomitant diuretics 1
- The maximum daily dose administered in clinical trials is 320 mg in divided doses 1
- Therapies should be adjusted no more frequently than every 2 weeks to target doses or maximally tolerated doses 2
Post-Myocardial Infarction Dosing
- May be initiated as early as 12 hours after a myocardial infarction 1
- Starting dose is 20 mg twice daily 1
- Patients may be uptitrated within 7 days to 40 mg twice daily, with subsequent titrations to a target maintenance dose of 160 mg twice daily, as tolerated 1
- Consider dosage reduction if symptomatic hypotension or renal dysfunction occurs 1
Special Considerations
- Monitor for hypotension, renal impairment, and hyperkalemia, especially when initiating therapy or increasing doses 2
- Many physicians use doses of valsartan for heart failure that are too low, which may not provide optimal benefits 2
- To achieve maximal benefits in heart failure with reduced ejection fraction (HFrEF), valsartan must be titrated to maximally tolerated doses 2
- Temporary dose reductions may be necessary for some patients, but efforts should be made to return to target doses when possible 2
- Once-daily dosing has been shown to have a similar safety and tolerability profile as twice-daily dosing in heart failure patients 4
Pediatric Dosing (1-16 Years of Age)
- The usual recommended starting dose is 1 mg/kg once daily (up to 40 mg total) 1
- A higher starting dose of 2 mg/kg may be considered when greater blood pressure reduction is needed 1
- Dosage should be adjusted according to blood pressure response and tolerability, up to a maximum of 4 mg/kg once daily (maximum daily dose 160 mg) 1
- Not recommended in children less than 1 year of age 1